 IRVINE, Calif., Jan. 07, 2020 GLOBE NEWSWIRE -- Biomerica Inc. NASDAQ: BMRA today announced that Houston Methodist part of Texas Medical Center, the largest medical complex in the world will start enrollment for the clinical trial of its new InFoods diagnostic-guided therapy DGT to alleviate Irritable Bowel Syndrome IBS symptoms. Houston Methodist will join Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, and the University of Michigan as primary enrollment centers for this study. 